Halozyme Therapeutics (HALO) announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products ...

KLP Kapitalforvaltning AS acquired a new stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) in the ...

Thrivent Financial for Lutherans reduced its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 83.2% in ...

Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Canada is currently the US’ largest uranium producer, delivering 27 percent of its total supply, followed by Australia and ...

Halozyme Therapeutics, Inc. (HALO) shares up after passing $1 billion in revenue for first time, strong guidance.

Highlights,PNC Financial Services Group Inc. adjusted its stake in Halozyme Therapeutics, reflecting a shift in market ...

Halozyme stock is in a consolidation pattern but its chart shows an alternate entry. The biotech name hit two milestones in 2024.

US biotech Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been "unwilling to engage with us to explore a potential combination." Halozyme made ...

Citing sources familiar with the matter, the report stated that biotech firm Halozyme Therapeutics claims the new version of Keytruda infringes on its patents. A possible patent dispute could be a ...